Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takeru Nakamoto is active.

Publication


Featured researches published by Takeru Nakamoto.


Nutrition Research and Practice | 2011

A mixture of Salacia oblonga extract and IP-PA1 reduces fasting plasma glucose (FPG) and low-density lipoprotein (LDL) cholesterol levels

Kazue Nakata; Yoshie Taniguchi; Noriko Yoshioka; Aya Yoshida; Hiroyuki Inagawa; Takeru Nakamoto; Hiroshi Yoshimura; Shin-ichiro Miyake; Chie Kohchi; Masahide Kuroki; Gen-Ichiro Soma

At present, lifestyle-related diseases are one of the most critical health issues worldwide. It has been reported that lipopolysaccharide derived from a Gram-negative bacteria (IP-PA1) symbiotic with wheat exhibited several advantageous biological effects, such as the reduction of plasma glucose levels in NOD mice and low-density lipoprotein (LDL) levels in WHHL rabbits. In this study, the beneficial effects on plasma glucose and lipids of a tea (SI tea) consisting of IP-PA1 and Salacia (which contains an inhibitor of α-glucosidase) were investigated in the KK-Ay/TaJcl type 2 diabetic model mice and in human subjects with premetabolic syndrome in a double-blind, randomized study. SI tea significantly decreased plasma glucose levels in KK-Ay/TaJcl mice. A clinical trial of SI tea was performed with 41 subjects between the ages of 40 and 69, who belonged either to a high plasma glucose group (HG: FPG 100-125 mg/dl) or to a hyperlipidemia group (HL: TG ≥ 150 mg/dl, or LDL ≥ 120 mg/dl, or HDL < 40 mg/dl). These subjects ingested either Salacia without IP-PA1 (the control) or SI tea. Blood samples were collected at 0, 30, and 60 days after initiating SI tea treatment, and were measured for FPG, HbA1c, TG, LDL, and HDL. These results showed that SI tea reduced FPG and HbA1c more rapidly than the control in the HL group, and also significantly improved LDL and HDL levels in the HG group. Thus, SI tea may be helpful in preventing lifestyle-related diseases.


American Journal of Surgery | 2003

Predictive factors and timing for liver recurrence after curative resection of gastric carcinoma

Satoshi Ohno; Toshiyuki Fujii; Shuhei Ueda; Takeru Nakamoto; Shoichi Kinugasa; Hiroshi Yoshimura; Mitsuo Tachibana; Hirofumi Kubota; Dipok Kumar Dhar; Naofumi Nagasue

BACKGROUND Advanced and reliable diagnostic methods in order to identify the site of recurrence of gastric cancer in an early stage are needed. METHODS One hundred twenty patients whose recurrence was confirmed after curative resection for gastric cancer were enrolled in this study. RESULTS Liver recurrence was evident in 41 patients. Advanced age, tumor invasion into subserosa, intestinal and mixed type of histology, Borrmann type 0 to 2, tumor diameter (<6.5 cm), and tumor marker (carcinoembryonic antigen and alpha-fetoprotein) elevation were related to liver recurrence. By logistic regression analysis, independent risk factors for liver recurrence included Borrmanns classification, histology, and tumor marker elevation. The median time from the primary operation to liver recurrence was shortest in the tumor marker elevation group when compared with other independent predictors. CONCLUSIONS This information may help to design a better follow-up program and appropriate treatment strategy for gastric cancer patients with liver metastasis.


Canadian Journal of Gastroenterology & Hepatology | 2003

Acute cholecystitis and cholelithiasis developed after esophagectomy

Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Dipok Kumar Dhar; Shuhei Ueda; Toshiyuki Fujii; Takeru Nakamoto; Ioannis D. Kyriazanos; Naofumi Nagasue

BACKGROUND Although the prevalence of gallstone disease after gastrectomy is reported to be high, its prevalence after esophagectomy is scarcely reported. MATERIALS AND METHODS Gallbladder disease following an esophagectomy was prospectively evaluated in 237 patients with esophageal cancer by abdominal ultrasonography twice a year up to five years postoperatively. The median follow-up period was 18.6 months. RESULTS One patient (0.4%) developed acute acalculous cholecystitis postoperatively, and 13 patients (5.5%) developed gallstone disease during the follow-up period. Nine (69%) of these 13 patients developed gallstone disease within two years, and another two patients developed the disease three years after esophagectomy. Another patient developed gallbladder debris at 35 months postoperatively, and one developed gallbladder polyps at 33 months. Seven of the 13 patients with gallstone disease underwent cholecystectomy between 13 and 125 months after esophagectomy: two developed acute cholecystitis; two had associated common bile duct stones; the remaining three patients had upper abdominal pain. Nine of the 13 patients who developed gallstone disease showed a history of alcoholism, whereas only 81 of 224 patients without gallstone disease had a similar history (P<0.05). CONCLUSION A certain number of patients with esophageal carcinoma and a history of alcoholism develop cholelithiasis within three years after esophagectomy, and subsequently undergo cholecystectomy during the follow-up period.


Food Science and Nutrition | 2014

Pantoea agglomerans lipopolysaccharide maintains bone density in premenopausal women: a randomized, double-blind, placebo-controlled trial

Kazue Nakata; Yoko Nakata; Hiroyuki Inagawa; Takeru Nakamoto; Hiroshi Yoshimura; Gen-Ichiro Soma

Lipopolysaccharide fromPantoea agglomerans (LPSp) facilitates Ca and P turnover in chicken calvaria and femurs. This study investigated osteoporosis prevention by the oral administration of LPSp in mice and in double-blind clinical tests. Using ovariectomized (OVX) osteoporosis mice model, we investigated the effects of LPSp on the bone density and Ca concentration after ingesting LPSp-containing water for 4 weeks. Oral administration of LPSp tended to suppress the decline in the bone density and the cortical bone thickness in the OVX mice. Moreover, the Ca concentrations were maintained in the OVX-LPSp mice. The effects of LPSp on bone turnover were tested in randomized and double-blind clinical test subjects, who were healthy women aged 40–79 years. The subjects ingested either soy milk without LPSp (control group) or with LPSp (LPSp group) for 3 months. The results showed that the LPSp group on premenopause maintained their bone density compared with the control group pre- and postmenopause. Moreover, these effects were maintained for 2 months postobservation. LPSp maintains bone volume and density in vivo. Thus, a combination of soy milk and LPSp may be useful for osteoporosis prevention.


Food Science and Nutrition | 2018

Effects of 3 months continuous intake of supplement containing Pantoea agglomerans LPS to maintain normal bloodstream in adults: Parallel double-blind randomized controlled study

Yoko Nakata; Chie Kohchi; Kazue Ogawa; Takeru Nakamoto; Hiroshi Yoshimura; Gen-Ichiro Soma

Abstract In this study, the effects on the maintenance of normal bloodstream by lipopolysaccharide (LPS) were investigated in the parallel‐group randomized double‐blind study using supplement containing Pantoea agglomerans LPS (201.5 μg/tablet as LPS). Screening was previously performed in the implementation of the study. Adult males and females with normal value to borderline (healthy subjects) in the hematologic parameters, for which reference values were given, were chosen in this study. The period of ingestion of the supplement was 3 months. As the result, a significant decrease in the rate of change (the ratio when the baseline was 1) of HbA1c, which is a glycative stress marker, was found in the group which ingested LPS supplement after 3 months. Also, a significant increase in the number of fingertip capillary vessels was found compared with the control group. From these results, the effects of the maintenance of bloodstream by ingestion of LPS were shown.


Journal of Surgical Oncology | 2004

Postoperative pulmonary complications are associated with worse short- and long-term outcomes after extended esophagectomy

Shoichi Kinugasa; Mitsuo Tachibana; Hiroshi Yoshimura; Shuhei Ueda; Toshiyuki Fujii; Dipok Kumar Dhar; Takeru Nakamoto; Naofumi Nagasue


Anticancer Research | 1998

Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.

Hiroyuki Inagawa; Takashi Nishizawa; Teruko Honda; Takeru Nakamoto; Koichi Takagi; Gen-Ichiro Soma


Anticancer Research | 2000

A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors.

Takeru Nakamoto; Hiroyuki Inagawa; Koichi Takagi; Gen-Ichiro Soma


Anticancer Research | 2000

Relationship between microvessel quantification and inducibility of endogenous tumor necrosis factor in colorectal adenocarcinoma.

Hiroshi Yoshimura; Chikamoto A; Teruko Honda; Tashiro K; Takeru Nakamoto; Masahiro Takano; Koichi Takagi; Naofumi Nagasue; Gen-Ichiro Soma


Anticancer Research | 2003

Prognostic significance of tumor necrosis factor receptor in colorectal adenocarcinoma.

Hiroshi Yoshimura; Dipok Kumar Dhar; Takeru Nakamoto; Tsukasa Kotoh; Masahiro Takano; Gen-Ichiro Soma; Naofumi Nagasue

Collaboration


Dive into the Takeru Nakamoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroyuki Inagawa

Tokyo University of Science

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Koichi Takagi

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar

Takashi Nishizawa

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge